[HTML][HTML] ¿ Por qué resulta cada vez más complicado “hacer lo que hay que hacer” y “dejar de hacer lo que no hay que hacer”? Estrategias para revertir las prácticas …

RMA Rodríguez, MPA Pena, TC Benejam - Atencion primaria, 2023 - Elsevier
En este trabajo se describen los factores que han propiciado la expansión de las prácticas
de bajo valor (PBV) junto con las principales iniciativas para revertirlas. El artículo destaca …

Patient engagement for patient safety: The why, what, and how of patient engagement for improving patient safety

C Kendir, R Fujisawa, ÓB Fernandes, K de Bienassis… - 2023 - oecd-ilibrary.org
Patients' and citizens' perspectives and their active engagement are critical to make health
systems safer and people-centred, and are key for co-designing health services and co …

[HTML][HTML] Medication safety, privacy, and stigma: A qualitative study of pharmacy opioid agonist treatment disruptions and adaptations in the 2022 Northern Rivers …

T Caruana - International Journal of Disaster Risk Reduction, 2024 - Elsevier
Background Opioid agonist treatment (OAT) involves the daily consumption of long-acting
opioid medications to assist in managing health and wellbeing issues related to illicit or high …

[PDF][PDF] Estimating the impact of enabling NHS information systems to share patients' medicines information digitally

R Elliott, E Camacho, S Gavan, R Keers, A Chuter - 2023 - research.manchester.ac.uk
Access to accurate medicines information is key to the management of patients, especially
when they transfer from one care setting to another, such as on admission to or discharge …

[HTML][HTML] Análisis del grado de implantación de las prácticas de prevención de errores de medicación en los hospitales españoles (2022)

MJ Otero, M Pérez-Encinas, B Tortajada-Goitia… - Farmacia …, 2023 - Elsevier
Objetivo conocer el grado de implantación de las prácticas de prevención de errores de
medicación en los hospitales españoles. Método estudio descriptivo multicéntrico del grado …

[HTML][HTML] [Translated article] Analysis of the degree of implementation of medication error prevention practices in Spanish hospitals (2022)

MJ Otero, M Pérez-Encinas, B Tortajada-Goitia… - Farmacia …, 2023 - Elsevier
Objective To assess the degree of implementation of medication error prevention practices
in Spanish hospitals. Method Descriptive multicenter study of the degree of implementation …

Economics of Medication Safety, with a Focus on Preventable Harm

RA Elliott - Principles and Practice of Pharmacovigilance and Drug …, 2024 - Springer
Adverse drug reactions can be an important cause of morbidity and mortality and may have
significant economic consequences, including the increased use of health services and …

Medication without harm: policy brief

P Galappatthy, A Mair, N Dhingra-Kumar - 2024 - napier-repository.worktribe.com
Executive summary Patient harm due to unsafe care is a leading cause of death and
disability worldwide, and most of such harm is avoidable (1). Harm due to medicines and …

Interpersonal and structural dimensions of opioid agonist treatment stigma in New South Wales community pharmacies

T Caruana - 2024 - unsworks.unsw.edu.au
Methadone and buprenorphine are effective medications for reducing health and social
harms related to heroin or other opioid drug use. However, people who receive these …

Why is it increasingly difficult to" do the right thing" and to" stop doing the wrong thing"? Strategies for reversing low-value practices

AR RM, AP MP, C Benejam - Atencion Primaria, 2023 - europepmc.org
En este trabajo se describen los factores que han propiciado la expansión de las prácticas
de bajo valor (PBV) junto con las principales iniciativas para revertirlas. El artículo destaca …